Dr. Amritha Suresh

Integrated Head and Neck Oncology Research Program

Dr. Amritha Suresh, Ph.D.

amritha.suresh@ms-mf.org

Dr. Amritha Suresh is a Principal Scientist of the Integrated Head and Neck Oncology Program, at Mazumdar Shaw Center for Translational Research (MSCTR), Narayana Health, Bangalore. She is also a faculty of the Roswell Park-Mazumdar Shaw Cancer Center collaborative Research program. Dr. Suresh completed her doctoral program from Center for Cellular and Molecular Biology (JNU) and served as a Research Associate at Head and Neck Institute, Amrita Institute of Medical Sciences and Research Center, Kochi during which period she was involved in setting up the research facility and the establishment of a Head and Neck tissue repository at the center. She is the recipient of the Young Investigator grant from DBT apart from other grants from DBT and ICMR. She is a member of the Head and Neck Cooperative group of India, a consortium involved in collaborative projects in head and neck cancer and member of executive committee of Foundation of Head and Neck Oncology of India. She has presented in multiple national and international conferences and has published in journals such as Translational Oncology, Head & Neck, Genomics, Oral Oncology and Genome Research.

Research interests:

Understanding the mechanisms of carcinogenesis and drug resistance is essential in order to develop clinically viable models that predict susceptibility to tumour development or resistance to treatment. Molecular profiling of head and neck cancers to identify the changes during carcinogenesis and drug resistance, assessing the known markers from the available databases are the main approaches adopted in the lab. Additionally, the role of CSCs in the processes is being explored. Carcinogen induced animal models are the major tool to assess their role in a systematic manner and these studies have already been initiated. CSCs have long been associated with treatment resistance; drug resistant cell lines been developed in the group are being used to delineate the underlying mechanisms.

Publications:

  1. Surendran S, Aboelkheir U, Tu AA, Magner WJ, Sigurdson SL, Merzianu M, Hicks WL Jr, Suresh A, Kirkwood KL, Kuriakose MA. T-Cell Infiltration and Immune Checkpoint Expression Increase in Oral Cavity Premalignant and Malignant Disorders. Biomedicines. 2022 Jul 30;10(8):1840. doi: 10.3390/biomedicines10081840, PMID: 36009387
  2. Birur N P, Song B, Sunny SP, G K, Mendonca P, Mukhia N, Li S, Patrick S, G S, A R S, Imchen T, Leivon ST, Kolur T, Shetty V, R VB, Vaibhavi D, Rajeev S Pednekar S, Banik AD, Ramesh RM, Pillai V, O S K, Smith PW, Sigamani A, Suresh A, Liang R, Kuriakose MA. Field validation of deep learning based Point-of-Care device for early detection of oral malignant and potentially malignant disorders. Sci Rep. 2022 Aug 22;12(1):14283. doi: 10.1038/s41598-022-18249-x. PMID: 35995987; PMCID: PMC9395355.
  3. Dwivedi N, Gangadharan C, Pillai V, Kuriakose MA, Suresh A, Das M. Establishment and characterization of novel autologous pair cell lines from two Indian non‑habitual tongue carcinoma patients. Oncol Rep. 2022 Sep;48(3):150. doi: 10.3892/or.2022.8362. Epub 2022 Jul 7. PMID: 35796014.
  4. Mendonca P, Sunny SP, Mohan U, Birur N P, Suresh A, Kuriakose MA. Non- invasive imaging of oral potentially malignant and malignant lesions: A systematic review and meta-analysis. Oral Oncol. 2022 Jul;130: 105877. doi: 10.1016/j.oraloncology.2022.105877. Epub 2022 May 23. PMID: 35617750.
  5. James BL, Sunny SP, Heidari AE, Ramanjinappa RD, Lam T, Tran AV, Kankanala S, Sil S, Tiwari V, Patrick S, Pillai V, Shetty V, Hedne N, Shah D, Shah N, Chen ZP, Kandasarma U, Raghavan SA, Gurudath S, Nagaraj PB, Wilder-Smith P, Suresh A, Kuriakose MA. Validation of a Point-of-Care Optical Coherence Tomography Device with Machine Learning Algorithm for Detection of Oral Potentially Malignant and Malignant Lesions. Cancers (Basel). 2021 Jul 17;13(14):3583. doi: 10.3390/cancers13143583. PMID: 34298796; PMCID: PMC8304149.
  6. Mohan U, Sunny SP, Mendonca P, Kuriakose MA, Kannan S, Suresh A. Systematic Review and Meta-Analysis to Identify the Immunocytochemical Markers Effective in Delineating Benign from Malignant Thyroid Lesions in FNAC Samples. Endocr Pathol. 2022 Jun; 33(2):243-256. doi: 10.1007/s12022-022-09721-5. Epub 2022 May 21. PMID: 35596875.
  7. Vishwanath D, Shanmugam A, Sundaresh M, Hariharan A, Saraf S, Bahadur U, Veeramachaneni V, Chandrasekhar N, Pillai V V, Bushan V, Shetty V, Subramaniam N, Kuriakose MA, Shivaprasad KS, Khadilkar K, Suresh A, Sum S, Lakhsmikantha A, Rekha PR, Zaidi SN, Gupta V, Kannan S. Development of a Low-cost NGS Test for the Evaluation of Thyroid Nodules. Indian J Surg Oncol. 2022 Mar;13(1):17-22. doi: 10.1007/s13193-019-01000-w. Epub 2019 Nov 20. PMID: 35462651; PMCID: PMC8986928.
  8. Figueroa KC, Song B, Sunny S, Li S, Gurushanth K, Mendonca P, Mukhia N, Patrick S, Gurudath S, Raghavan S, Imchen T, Leivon ST, Kolur T, Shetty V, Bushan V, Ramesh R, Pillai V, Wilder-Smith P, Sigamani A, Suresh A, Kuriakose MA, Birur P, Liang R. Interpretable deep learning approach for oral cancer classification using guided attention inference network. J Biomed Opt. 2022 Jan;27(1):015001. doi: 10.1117/1.JBO.27.1.015001. PMID: 35023333; PMCID: PMC8754153.
  9. Song B, Sunny S, Li S, Gurushanth K, Mendonca P, Mukhia N, Patrick S, Gurudath S, Raghavan S, Imchen T, Leivon S, Kolur T, Shetty V, Bushan V, Ramesh R, Lima N, Pillai V, Wilder-Smith P, Sigamani A, Suresh A, Kuriakose M, Birur P, Liang R. Mobile-based oral cancer classification for point-of-care screening. J Biomed Opt. 2021 Jun;26(6):065003. doi: 10.1117/1.JBO.26.6.065003. PMID: 34164967; PMCID: PMC8220969.
  10. Song B, Sunny S, Li S, Gurushanth K, Mendonca P, Mukhia N, Patrick S, Gurudath S, Raghavan S, Tsusennaro I, Leivon ST, Kolur T, Shetty V, Bushan VR, Ramesh R, Peterson T, Pillai V, Wilder-Smith P, Sigamani A, Suresh A, Kuriakose MA, Birur P, Liang R. Bayesian deep learning for reliable oral cancer image classification. Biomed Opt Express. 2021 Sep 20;12(10):6422-6430. doi: 10.1364/BOE.432365. PMID: 34745746; PMCID: PMC8547976.
  11. Song B, Li S, Sunny S, Gurushanth K, Mendonca P, Mukhia N, Patrick S, Gurudath S, Raghavan S, Tsusennaro I, Leivon ST, Kolur T, Shetty V, Bushan V, Ramesh R, Peterson T, Pillai V, Wilder-Smith P, Sigamani A, Suresh A, Kuriakose MA, Birur P, Liang R. Classification of imbalanced oral cancer image data from high-risk population. J Biomed Opt. 2021 Oct;26(10):105001. doi: 10.1117/1.JBO.26.10.105001. PMID: 34689442; PMCID: PMC8536945.
  12. Kossatz S, Pirovano G, Demétrio De Souza França P, Strome AL, Sunny SP, Zanoni DK, Mauguen A, Carney B, Brand C, Shah V, Ramanajinappa RD, Hedne N, Birur P, Sihag S, Ghossein RA, Gönen M, Strome M, Suresh A, Molena D, Ganly I, Kuriakose MA, Patel SG, Reiner T. Validation of the use of a fluorescent PARP1 inhibitor for the detection of oral, oropharyngeal and oesophageal epithelial cancers. Nat Biomed Eng. 2020 Mar;4(3):272-285. doi: 10.1038/s41551-020-0526-9. Epub 2020 Mar 12. PubMed PMID: 32165735; PubMed Central PMCID: PMC7136849.
  13. Sivadasan P, Gupta MK, Sathe G, Sudheendra HV, Sunny SP, Renu D, Hari PS, Gowda H, Suresh A, Kuriakose MA, Sirdeshmukh R. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection. J Proteomics. 2020 Feb 10;212:103574. doi: 10.1016/j.jprot.2019.103574. Epub 2019 Nov 7. PubMed PMID: 31706945.
  14. Sunny S, Baby A, James BL, Balaji D, N V A, Rana MH, Gurpur P, Skandarajah A, D’Ambrosio M, Ramanjinappa RD, Mohan SP, Raghavan N, Kandasarma U, N S, Raghavan S, Hedne N, Koch F, Fletcher DA, Selvam S, Kollegal M, N PB, Ladic L, Suresh A, Pandya HJ, Kuriakose MA. A smart tele-cytology point-of-care platform for oral cancer screening. PLoS One. 2019;14(11):e0224885. doi: 10.1371/journal.pone.0224885. eCollection 2019. PubMed PMID: 31730638; PubMed Central PMCID: PMC6857853.
  15. Uthoff RD, Song B, Sunny S, Patrick S, Suresh A, Kolur T, Gurushanth K, Wooten K, Gupta V, Platek ME, Singh AK, Wilder-Smith P, Kuriakose MA, Birur P, Liang R. Small form factor, flexible, dual-modality handheld probe for smartphone-based, point-of-care oral and oropharyngeal cancer screening. J Biomed Opt. 2019 Oct;24(10):1-8. doi: 10.1117/1.JBO.24.10.106003. PubMed PMID: 31642247; PubMed Central PMCID: PMC6826203.
  16. Johnson A, Baeten J, Patel K, Killian M, Sunny S, Suresh A, Uma K, Birur P, Kuriakose M, Kademani D. Evaluation of a Lectin-Based Imaging System for the Chairside Detection of Oral Dysplasia and Malignancy. J Oral Maxillofac Surg. 2019 Sep;77(9):1941-1951. doi: 10.1016/j.joms.2019.03.012. Epub 2019 Mar 26. PubMed PMID: 31004587.
  17. Reddy RB, Khora SS, Suresh A. Molecular prognosticators in clinically and pathologically distinct cohorts of head and neck squamous cell carcinoma-A meta-analysis approach. PLoS One. 2019;14(7):e0218989. doi: 10.1371/journal.pone.0218989. eCollection 2019. PubMed PMID: 31310629; PubMed Central PMCID: PMC6634788.
  18. Kulsum S, Raju N, Raghavan N, Ramanjanappa RDR, Sharma A, Mehta A, Kuriakose MA, Suresh A. Cancer stem cells and fibroblast niche cross talk in an in-vitro oral dysplasia model. Mol Carcinog. 2019 May;58(5):820-831. doi: 10.1002/mc.22974. Epub 2019 Jan 31. PubMed PMID: 30644602.
  19. Sunny SP, Agarwal S, James BL, Heidari E, Muralidharan A, Yadav V, Pillai V, Shetty V, Chen Z, Hedne N, Wilder-Smith P, Suresh A, Kuriakose MA. Intra-operative point-of-procedure delineation of oral cancer margins using optical coherence tomography. Oral Oncol. 2019 May;92:12-19. doi: 10.1016/j.oraloncology.2019.03.006. Epub 2019 Mar 15. PubMed PMID: 31010617; PubMed Central PMCID: PMC6954689.
  20. Mohanta S, Sekhar Khora S, Suresh A. Cancer Stem Cell based molecular predictors of tumor recurrence in Oral squamous cell carcinoma. Arch Oral Biol. 2019 Mar;99:92-106. doi: 10.1016/j.archoralbio.2019.01.002. Epub 2019 Jan 4. PubMed PMID: 30641296.
  21. Uthoff RD, Song B, Sunny S, Patrick S, Suresh A, Kolur T, Keerthi G, Spires O, Anbarani A, Wilder-Smith P, Kuriakose MA, Birur P, Liang R. Point-of-care, smartphone-based, dual-modality, dual-view, oral cancer screening device with neural network classification for low-resource communities. PLoS One. 2018;13(12):e0207493. doi: 10.1371/journal.pone.0207493. eCollection 2018. PubMed PMID: 30517120; PubMed Central PMCID: PMC6281283.
  22. Song B, Sunny S, Uthoff RD, Patrick S, Suresh A, Kolur T, Keerthi G, Anbarani A, Wilder-Smith P, Kuriakose MA, Birur P, Rodriguez JJ, Liang R. Automatic classification of dual-modalilty, smartphone-based oral dysplasia and malignancy images using deep learning. Biomed Opt Express. 2018 Nov 1;9(11):5318-5329. doi: 10.1364/BOE.9.005318. eCollection 2018 Nov 1. PubMed PMID: 30460130; PubMed Central PMCID: PMC6238918.
  23. Palve V, Bagwan J, Krishnan NM, Pareek M, Chandola U, Suresh A, Siddappa G, James BL, Kekatpure V, Kuriakose MA, Panda B. Detection of High-Risk Human Papillomavirus in Oral Cavity Squamous Cell Carcinoma Using Multiple Analytes and Their Role in Patient Survival. J Glob Oncol. 2018 Nov;4:1-33. doi: 10.1200/JGO.18.00058. PubMed PMID: 30398949; PubMed Central PMCID: PMC7010445.
  24. Birur NP, Patrick S, Bajaj S, Raghavan S, Suresh A, Sunny SP, Chigurupati R, Wilder-Smith P, Gurushanth K, Gurudath S, Rao P, Kuriakose MA. A Novel Mobile Health Approach to Early Diagnosis of Oral Cancer. J Contemp Dent Pract. 2018 Sep 1;19(9):1122-1128. PubMed PMID: 30287715; PubMed Central PMCID: PMC6455929.
  25. Palve V, Pareek M, Krishnan NM, Siddappa G, Suresh A, Kuriakose MA, Panda B. A minimal set of internal control genes for gene expression studies in head and neck squamous cell carcinoma. PeerJ. 2018;6:e5207. doi: 10.7717/peerj.5207. eCollection 2018. PubMed PMID: 30128175; PubMed Central PMCID: PMC6097490.
  26. Kumar VV, James BL, Ruß M, Mikkat S, Suresh A, Kämmerer PW, Glocker MO. Proteome analysis reveals that de novo regenerated mucosa over fibula flap-reconstructed mandibles resembles mature keratinized oral mucosa. Oral Oncol. 2018 Mar;78:207-215. doi: 10.1016/j.oraloncology.2018.01.017. Epub 2018 Feb 20. PubMed PMID: 29496052.
  27. Baeten J, Johnson A, Sunny S, Suresh A, Birur P, Uma K, Kademani D. Chairside molecular imaging of aberrant glycosylation in subjects with suspicious oral lesions using fluorescently labeled wheat germ agglutinin. Head Neck. 2018 Feb;40(2):292-301. doi: 10.1002/hed.24943. Epub 2017 Sep 30. PubMed PMID: 28963821.
  28. Surendran S, Siddappa G, Mohan A, Hicks W Jr, Jayaprakash V, Mimikos C, Mahri M, Almarzouki F, Morrell K, Ravi R, Govindan S, Sushma CN, Raghavan N, Birur P, Ilayaraja J, Merzianu M, Reid M, Suresh A, Kuriakose MA. Cancer stem cell and its niche in malignant progression of oral potentially malignant disorders. Oral Oncol. 2017 Dec;75:140-147. doi: 10.1016/j.oraloncology.2017.11.003. Epub 2017 Nov 12. PubMed PMID: 29224811; PubMed Central PMCID: PMC5880641.
  29. Skandarajah A, Sunny SP, Gurpur P, Reber CD, D’Ambrosio MV, Raghavan N, James BL, Ramanjinappa RD, Suresh A, Kandasarma U, Birur P, Kumar VV, Galmeanu HC, Itu AM, Modiga-Arsu M, Rausch S, Sramek M, Kollegal M, Paladini G, Kuriakose M, Ladic L, Koch F, Fletcher D. Mobile microscopy as a screening tool for oral cancer in India: A pilot study. PLoS One. 2017;12(11):e0188440. doi: 10.1371/journal.pone.0188440. eCollection 2017. PubMed PMID: 29176904; PubMed Central PMCID: PMC5703562.
  30. Siddappa G, Kulsum S, Ravindra DR, Kumar VV, Raju N, Raghavan N, Sudheendra HV, Sharma A, Sunny SP, Jacob T, Kuruvilla BT, Benny M, Antony B, Seshadri M, Lakshminarayan P, Hicks W Jr, Suresh A, Kuriakose MA. Curcumin and metformin-mediated chemoprevention of oral cancer is associated with inhibition of cancer stem cells. Mol Carcinog. 2017 Nov;56(11):2446-2460. doi: 10.1002/mc.22692. Epub 2017 Jul 13. PubMed PMID: 28618017.
  31. Mohanta S, Siddappa G, Valiyaveedan SG, Dodda Thimmasandra Ramanjanappa R, Das D, Pandian R, Khora SS, Kuriakose MA, Suresh A. Cancer stem cell markers in patterning differentiation and in prognosis of oral squamous cell carcinoma. Tumour Biol. 2017 Jun;39(6):1010428317703656. doi: 10.1177/1010428317703656. PubMed PMID: 28631562.
  32. Bhat AR, Gupta MK, Krithivasan P, Dhas K, Nair J, Reddy RB, Sudheendra HV, Chavan S, Vardhan H, Darsi S, Balakrishnan L, Katragadda S, Kekatpure V, Suresh A, Tata P, Panda B, Kuriakose MA, Sirdeshmukh R. Sample preparation method considerations for integrated transcriptomic and proteomic analysis of tumors. Proteomics Clin Appl. 2017 Mar;11(3-4). doi: 10.1002/prca.201600100. Epub 2016 Nov 28. PubMed PMID: 27801551.
  33. Kulsum S, Sudheendra HV, Pandian R, Ravindra DR, Siddappa G, R N, Chevour P, Ramachandran B, Sagar M, Jayaprakash A, Mehta A, Kekatpure V, Hedne N, Kuriakose MA, Suresh A. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition. Mol Carcinog. 2017 Feb;56(2):694-711. doi: 10.1002/mc.22526. Epub 2016 Aug 4. PubMed PMID: 27380877.
  34. Krishnan NM, Dhas K, Nair J, Palve V, Bagwan J, Siddappa G, Suresh A, Kekatpure VD, Kuriakose MA, Panda B. A Minimal DNA Methylation Signature in Oral Tongue Squamous Cell Carcinoma Links Altered Methylation with Tumor Attributes. Mol Cancer Res. 2016 Sep;14(9):805-19. doi: 10.1158/1541-7786.MCR-15-0395. Epub 2016 Jun 10. PubMed PMID: 27288358.
  35. Kuriakose MA, Ramdas K, Dey B, Iyer S, Rajan G, Elango KK, Suresh A, Ravindran D, Kumar RR, R P, Ramachandran S, Kumar NA, Thomas G, Somanathan T, Ravindran HK, Ranganathan K, Katakam SB, Parashuram S, Jayaprakash V, Pillai MR. A Randomized Double-Blind Placebo-Controlled Phase IIB Trial of Curcumin in Oral Leukoplakia. Cancer Prev Res (Phila). 2016 Aug;9(8):683-91. doi: 10.1158/1940-6207.CAPR-15-0390. Epub 2016 Jun 7. PubMed PMID: 27267893.
  36. Kekatpure VD, Bs N, Wang H, Zhou XK, Kandasamy C, Sunny SP, Suresh A, Milne GL, Kuriakose MA, Dannenberg AJ. Elevated Levels of Urinary PGE-M Are Found in Tobacco Users and Indicate a Poor Prognosis for Oral Squamous Cell Carcinoma Patients. Cancer Prev Res (Phila). 2016 Jun;9(6):428-36. doi: 10.1158/1940-6207.CAPR-15-0412. Epub 2016 Apr 4. PubMed PMID: 27045033.
  37. Reddy RB, Bhat AR, James BL, Govindan SV, Mathew R, Ravindra DR, Hedne N, Illiayaraja J, Kekatpure V, Khora SS, Hicks W, Tata P, Kuriakose MA, Suresh A. Meta-Analyses of Microarray Datasets Identifies ANO1 and FADD as Prognostic Markers of Head and Neck Cancer. PLoS One. 2016;11(1):e0147409. doi: 10.1371/journal.pone.0147409. eCollection 2016. PubMed PMID: 26808319; PubMed Central PMCID: PMC4726811.
  38. Birur PN, Sunny SP, Jena S, Kandasarma U, Raghavan S, Ramaswamy B, Shanmugam SP, Patrick S, Kuriakose R, Mallaiah J, Suresh A, Chigurupati R, Desai R, Kuriakose MA. Mobile health application for remote oral cancer surveillance. J Am Dent Assoc. 2015 Dec;146(12):886-94. doi: 10.1016/j.adaj.2015.05.020. PubMed PMID: 26610833.
  39. Krishnan N, Gupta S, Palve V, Varghese L, Pattnaik S, Jain P, Khyriem C, Hariharan A, Dhas K, Nair J, Pareek M, Prasad V, Siddappa G, Suresh A, Kekatpure V, Kuriakose M, Panda B. Integrated analysis of oral tongue squamous cell carcinoma identifies key variants and pathways linked to risk habits, HPV, clinical parameters and tumor recurrence. F1000Res. 2015;4:1215. doi: 10.12688/f1000research.7302.1. eCollection 2015. PubMed PMID: 26834999; PubMed Central PMCID: PMC4706066.
  40. Sivadasan P, Gupta MK, Sathe GJ, Balakrishnan L, Palit P, Gowda H, Suresh A, Kuriakose MA, Sirdeshmukh R. Human salivary proteome–a resource of potential biomarkers for oral cancer. J Proteomics. 2015 Sep 8;127(Pt A):89-95. doi: 10.1016/j.jprot.2015.05.039. Epub 2015 Jun 12. PubMed PMID: 26073025.
  41. Bothwell KD, Shaurova T, Merzianu M, Suresh A, Kuriakose MA, Johnson CS, Hershberger PA, Seshadri M. Impact of Short-term 1,25-Dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer. Cancer Prev Res (Phila). 2015 Sep;8(9):765-76. doi: 10.1158/1940-6207.CAPR-14-0454. Epub 2015 Jun 22. PubMed PMID: 26100522; PubMed Central PMCID: PMC4560661.
  42. Sivadasan P, Kumar Gupta M, Sathe GJ, Balakrishnan L, Palit P, Gowda H, Suresh A, Abraham Kuriakose M, Sirdeshmukh R. Data from human salivary proteome – A resource of potential biomarkers for oral cancer. Data Brief. 2015 Sep;4:374-8. doi: 10.1016/j.dib.2015.06.014. eCollection 2015 Sep. PubMed PMID: 26217819; PubMed Central PMCID: PMC4510580.
  43. Govindan SV, Kulsum S, Pandian RS, Das D, Seshadri M, Hicks W Jr, Kuriakose MA, Suresh A. Establishment and characterization of triple drug resistant head and neck squamous cell carcinoma cell lines. Mol Med Rep. 2015 Aug;12(2):3025-32. doi: 10.3892/mmr.2015.3768. Epub 2015 May 12. PubMed PMID: 25962396.
  44. Kekatpure VD, Singh M, Selvam S, Shetkar G, Hedne NC, Trivedi NP, Siddappa G, Govindan SV, Suresh A, Rangarajan B, Dannenberg AJ, Kuriakose MA. Factors predicting outcome after salvage treatment for stage IV oral squamous cell carcinoma: Evidence of the potential importance of the cyclooxygenase-2-prostaglandin E2 pathway. Head Neck. 2015 Aug;37(8):1142-9. doi: 10.1002/hed.23721. Epub 2014 Nov 15. PubMed PMID: 24771596.
  45. Simple M, Suresh A, Das D, Kuriakose MA. Cancer stem cells and field cancerization of oral squamous cell carcinoma. Oral Oncol. 2015 Jul;51(7):643-51. doi: 10.1016/j.oraloncology.2015.04.006. Epub 2015 Apr 23. Review. PubMed PMID: 25920765.
  46. Nair J, Jain P, Chandola U, Palve V, Vardhan NR, Reddy RB, Kekatpure VD, Suresh A, Kuriakose MA, Panda B. Gene and miRNA expression changes in squamous cell carcinoma of larynx and hypopharynx. Genes Cancer. 2015 Jul;6(7-8):328-40. doi: 10.18632/genesandcancer.69. PubMed PMID: 26413216; PubMed Central PMCID: PMC4575920.
  47. Baeten J, Suresh A, Johnson A, Patel K, Kuriakose M, Flynn A, Kademani D. Molecular imaging of oral premalignant and malignant lesions using fluorescently labeled lectins. Transl Oncol. 2014 Apr;7(2):213-20. doi: 10.1016/j.tranon.2014.02.006. Epub 2014 Mar 4. PubMed PMID: 24913673; PubMed Central PMCID: PMC4101339.
  48. Suresh A, Vannan M, Kumaran D, Gümüs ZH, Sivadas P, Murugaian EE, Kekatpure V, Iyer S, Thangaraj K, Kuriakose MA. Resistance/response molecular signature for oral tongue squamous cell carcinoma. Dis Markers. 2012;32(1):51-64. doi: 10.3233/DMA-2012-0860. PubMed PMID: 22297602; PubMed Central PMCID: PMC3826923.
  49. Elango KJ, Anandkrishnan N, Suresh A, Iyer SK, Ramaiyer SK, Kuriakose MA. Mouth self-examination to improve oral cancer awareness and early detection in a high-risk population. Oral Oncol. 2011 Jul;47(7):620-4. doi: 10.1016/j.oraloncology.2011.05.001. Epub 2011 Jun 8. PubMed PMID: 21646040.
  50. Elango KJ, Suresh A, Erode EM, Subhadradevi L, Ravindran HK, Iyer SK, Iyer SK, Kuriakose MA. Role of human papilloma virus in oral tongue squamous cell carcinoma. Asian Pac J Cancer Prev. 2011;12(4):889-96. PubMed PMID: 21790221.
  51. Jehan Z, Vallinayagam S, Tiwari S, Pradhan S, Singh L, Suresh A, Reddy HM, Ahuja YR, Jesudasan RA. Novel noncoding RNA from human Y distal heterochromatic block (Yq12) generates testis-specific chimeric CDC2L2. Genome Res. 2007 Apr;17(4):433-40. doi: 10.1101/gr.5155706. Epub 2006 Nov 9. PubMed PMID: 17095710; PubMed Central PMCID: PMC1832090.
  52. Suresh A, Shah V, Rani DS, Singh BN, Prasad GU, Subramanian S, Kumar S, Singh L. A mouse gene encoding a novel member of the WD family of proteins is highly conserved and predominantly expressed in the testis (Wdr13). Mol Reprod Dev. 2005 Nov;72(3):299-310. doi: 10.1002/mrd.20362. PubMed PMID: 16094675.
  53. Singh BN, Suresh A, UmaPrasad G, Subramanian S, Sultana M, Goel S, Kumar S, Singh L. A highly conserved human gene encoding a novel member of WD-repeat family of proteins (WDR13). Genomics. 2003 Mar;81( 3):315-28. doi: 10.1016/s0888-7543(02)00036-8. PubMed PMID: 12659815.